Perkins Capital Management’s Miromatrix Medical Inc. Common Stock MIRO Stock Holding History

Perkins Capital Management’s Portfolio MIRO Stock Details MIRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-119,320	Closed	-$156K	–	100
2023 Q3	$156K	Hold	119,320	–	–	0.15%	84
2023 Q2	$209K	Sell	119,320 -32,000	-21%	-$42.2K	0.18%	78
2023 Q1	$254K	Buy	+151,320	New	+$393K	0.24%	76
2022 Q3	–	Sell	-21,880	Closed	-$87K	–	109
2022 Q2	$87K	Hold	21,880	–	–	0.09%	93
2022 Q1	$87K	Hold	21,880	–	–	0.07%	101
2021 Q4	$103K	Sell	21,880 -25,340	-54%	-$180K	0.07%	99
2021 Q3	$329K	Sell	47,220 -2,780	-6%	-$26.2K	0.2%	83
2021 Q2	$583K	Buy	+50,000	New	+$644K	0.33%	68

Perkins Capital Management's MIRO Position: Q4 2023 in Review

Perkins Capital Management sold out of Miromatrix Medical Inc. Common Stock (MIRO) in Q4 2023, closing a stake of 119,320 shares — an estimated $156K sold.

Perkins Capital Management first reported a position in MIRO in Q2 2021 and held it in 8 quarters. The position peaked at $583K in Q2 2021. 0 funds tracked by Wall St. Rank hold MIRO as of Q4 2023.

Perkins Capital Management reported no remaining Miromatrix Medical Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Perkins Capital Management sold 119,320 Miromatrix Medical Inc. Common Stock shares in Q4 2023, an estimated $156K.
Perkins Capital Management first reported a position in Miromatrix Medical Inc. Common Stock in Q2 2021 and held it in 8 quarters.
Perkins Capital Management's Miromatrix Medical Inc. Common Stock position peaked at $583K in Q2 2021.
0 funds tracked by Wall St. Rank held Miromatrix Medical Inc. Common Stock as of Q4 2023.

Based on Perkins Capital Management's 13F filing for Q4 2023, filed 22 Jan 2024.